DIRS.INFO The most relevant business & tech news

☆ Bond auctions are a bigger deal than usual this week. The first went the way of the bulls
▼ + stars: | 2024-04-23 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

Treasury yields dip: In addition to earnings, the other part of the market's gauntlet this week is a trio of huge Treasury auctions. The PMI data was softer than expected, confirming signs of the economic "brown shoots" that Jim Cramer has recently been flagging. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Jim, Jim Cramer's Organizations: CNBC, Nasdaq, Dow Jones, Treasury, P Global, PMI, Federal, Amazon, Foods, Apple, Developers, Tesla, Enphase, Texas, Boeing, Boston Scientific, Otis Worldwide, Jim Cramer's Charitable Locations: Enphase Energy, Humana

☆ 6 portfolio stock earnings and the Fed's favorite inflation gauge dominate the week ahead
▼ + stars: | 2024-04-20 | by ( Zev Fima | ) www.cnbc.com time to read: +11 min

The Nasdaq sank 2% on Friday as Netflix dropped nearly 11% post-earnings and Club stock Nvidia fell 10%, entering bear market territory but still up more than 50% in 2024. Following a much stronger-than-expected March retail sales report last month, fresh economic data and six Club stock earnings will take center stage in the week ahead. While lower rates may help stock multiples, that is not a sustainable path to higher equity prices over time. Earnings : The latest quarterly reporting season is starting to ramp into high gear with six Club names set to report next week. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Dow, Jerome Powell, Jim Cramer, Mark, Meta, Bing, Ford, Vimal, Lockheed Martin, Clark, Philip Morris, Sherwin, Williams, Baker Hughes, Lam, Northrop, Dr Pepper, CARR, Edwards Lifesciences, Jim Cramer's, Jim, Michael M Organizations: Nasdaq, Netflix, Nvidia, Dow Jones, Federal, Fed, Hamas, Gross, Google, Reality Labs, General Motors, Honeywell, Microsoft, Verizon Communications, Albertsons Companies, SAP, Cadence Design Systems, United Parcel Service, General Electric, GE, PepsiCo, Lockheed, Spotify Technology, RTX Corporation, JetBlue Airways, Halliburton, HAL, Philip Morris International, Quest Diagnostics, Texas Instruments, Seagate Technology, Mattel, Veralto Corporation, Boeing, General Dynamics, Boston, Hilton, Fisher, Otis Worldwide, IBM, Grill, Viking Therapeutics, Lam Research, Whirlpool, WM, Honeywell International, Royal Caribbean Cruises, American Airlines, Altria, Newmont, Caterpillar, Southwest Airlines, Myers Squibb, AstraZeneca, Mobileye, Northrop Grumman, CNBC, Comcast, Merck, Dow Inc, Carrier Global, Union Pacific, Intel, Western, Mobile, L3Harris Technologies, Exxon Mobil, Chevron, Colgate, Palmolive, HCA Healthcare, Charter Communications, Newell Brands, Jim Cramer's Charitable, Traders, New York Stock Exchange, Santiago, Getty Locations: Israel, Iran, Ukraine, destocking, China, Cleveland, Freeport, McMoRan, Kimberly, Masco, Bristol, New York City

☆ These companies slated to report next week have a history of beating earnings estimates, including one tech giant
▼ + stars: | 2024-04-18 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

Nearly 76% of companies that have reported have beaten earnings expectations, while 59% have come in above analysts' expectations for revenue. A diverse group of companies reports results next week, on track to be the busiest one of the season. A company's earnings results are, of course, integral to both its near- and long-term performance. As a result, CNPC Pro screened stocks slated to report their earnings next week for those that have a history of beating analysts' expectations. The workflow automation platform beats earnings expectations 89% of the time.

Persons: They've, Meta, Piper Sandler, Five9, Baird, William Power, —, Robert Hum, Fred Imbert Organizations: Dow Jones, Technology, Microsoft, Meta, Humana, Comcast, Chubb, Visa, Investment Group, JPMorgan, Citi, Cloud Locations: industrials

☆ Johnson & Johnson tops quarterly profit estimates as medical device sales jump
▼ + stars: | 2024-04-16 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street's expectations as sales in its medical devices business surged. The company reported $21.38 billion in total sales for the first three months of 2024, up more than 2% from the same quarter in 2023. The company now expects sales of $88 billion to $88.4 billion. Separately on Tuesday, J&J said it will increase its quarterly dividend to $1.24 per share, up 4.2% from $1.19 per share.

Persons: Johnson, J Organizations: Johnson, J's, Humana, UnitedHealth, Elevance, LSEG, & $ Locations: Irvine , California

☆ This U.S. company tested a 4-day workweek—and says it made workers happier and more productive
▼ + stars: | 2024-04-05 | by ( Morgan Smith | ) www.cnbc.com time to read: +4 min

A four-day workweek could be the antidote to employee burnout. The biggest benefits of a four-day workweek: Happier, more productive employeesExos reports that six months after introducing a four-day workweek, business performance and productivity remained high, revenue increased and turnover dropped. But the biggest benefit of embracing a four-day workweek has been the increased efficiency, says Hill. Roughly 85% of Exos' employees work in-person, while the remaining 15% are hybrid or remote. How the four-day workweek is gaining momentum

Persons: Greg Hill, There's, Adam Grant, Marissa Shandell —, Exos, Hill Organizations: Fortune, Adobe, Humana, CNBC, Wharton School, Business Locations: U.S

☆ Tuesday’s rapid fire: GE Aerospace, GE Vernova, UnitedHealth, Humana, Tesla, PVH and Paychex
▼ + stars: | 2024-04-02 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTuesday’s rapid fire: GE Aerospace, GE Vernova, UnitedHealth, Humana, Tesla, PVH and PaychexCNBC’s Jim Cramer on Tuesday discussed market-moving headlines involving GE Aerospace, health insurers including Humana, Tesla and more.

Persons: Paychex CNBC’s Jim Cramer Organizations: GE Aerospace, GE Vernova, Tesla, Humana

☆ Stocks making the biggest moves midday: Tesla, GE Vernova, UnitedHealth Group and more
▼ + stars: | 2024-04-02 | by ( Hakyung Kim | ) www.cnbc.com time to read: +3 min

Tesla — Tesla shares sank more than 6% after the electric vehicle maker reported an 8.5% year-over-year decline in deliveries in the first quarter. GE Vernova — Shares jumped more than 3% after GE Vernova started trading on the New York Stock Exchange on Tuesday under the ticker "GEV," following its spinoff from General Electric. Shares of GE Aerospace , which was formerly General Electric and is keeping the "GE" ticker symbol, gained roughly 1%. Figs — Shares of the health-care apparel maker slipped 6.2% following a Bank of America downgrade to underperform from neutral. Horton — The homebuilder's shares slipped 3.7%.

Persons: PVH, Calvin Klein, Tommy Hilfiger, Blackstone, Nextracker, Horton —, Wedbush, Horton, Brent Bowman, Tim Cabral, —, Sarah Min, Alex Harring, Samantha Subin Organizations: GE, —, GE Vernova, New York Stock Exchange, General Electric, GE Aerospace, SLB, CVS, Health, Medicare, Medicaid Services, CVS Health, UnitedHealth, Endeavor, Silver, Blackstone —, UBS, Barclays, Bank of America, Veeva Locations: Europe, D.R

☆ Stocks making the biggest moves premarket: PVH, UnitedHealth, CVS Health, ChampionX and more
▼ + stars: | 2024-04-02 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

PVH — Shares of the Calvin Klein and Tommy Hilfiger parent tanked more than 21% on weak revenue guidance for the first quarter and full year. Humana , UnitedHealth — Health insurance managed care stocks declined after the Center for Medicare and Medicaid Services announced rates for the 2025 calendar year will increase 3.7%, as previously proposed. Humana shed 9.6%, while CVS Health tanked 5.3%. GE Aerospace — General Electric shares ticked higher by 0.6% after the company completed spinning off its energy business from its aerospace business. GE Vernova will begin trading on the New York Stock Exchange at market open under the ticker GEV, while General Electric — which becomes GE Aerospace — will keep the GE ticker symbol.

Persons: Calvin Klein, Tommy Hilfiger, Estee Lauder —, Estee Lauder, Blackstone — Blackstone, —, Sarah Min, Hakyung Kim, Jesse Pound Organizations: Center, Medicare, Services, CVS, UnitedHealth, Citi, Blackstone, UBS, Trump Media, Technology, Truth, Bank of America, GE Aerospace — General Electric, GE Vernova, New York Stock Exchange, General, GE Aerospace, GE, SLB Locations: Europe

☆ Jim Cramer shares his thoughts on GE Aerospace, GE Vernova, UnitedHealth, Tesla, PVH and Paychex
▼ + stars: | 2024-04-02 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +2 min

Jim Cramer's daily rapid fire looks at stocks in the news outside the CNBC Investing Club portfolio. GE Aerospace , GE Vernova : General Electric completed its breakup into three publicly traded companies. Its renewable energy and power unit began trading Tuesday as GE Vernova with the stock ticker GEV. The GE Vernova business "turned out to be far better than I thought," Cramer acknowledged. Cramer's CNBC Investing Club has owned shares of GE Healthcare for nearly a year .

Persons: Jim Cramer's, Jim Cramer, Cramer, Humana, Biden, It's, Tesla, Calvin Klein, Tommy Hilfiger Organizations: CNBC, Club, GE Aerospace, GE Vernova, Electric, GE, Boeing, GE Healthcare, UnitedHealth, Ford, PVH Corp, TJX Companies

☆ Health insurer stocks slide as final Medicare Advantage rates disappoint
▼ + stars: | 2024-04-02 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Shares of U.S. health insurers fell Tuesday after the Biden administration didn't boost payments for private Medicare plans as much as the insurance industry and investors had hoped. Shares of CVS Health fell more than 8% on Tuesday, while UnitedHealth Group 's stock slid nearly 7%. Shares of Elevance Health dropped more than 3% and Centene 's stock fell 6%. Meanwhile, Humana 's stock fell more than 10%. The health-care giant is far more dependent on those private Medicare plans, known as Medicare Advantage, than its rivals.

Persons: Biden, Humana Organizations: Humana Inc, CVS Health, Elevance Health Locations: Louisville , Kentucky, U.S

☆ Three-Stock Lunch: Humana, D.R. Horton & Tesla
▼ + stars: | 2024-04-02 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThree-Stock Lunch: Humana, D.R. Horton & TeslaScott Nations, Nations Indexes president, joins 'Power Lunch' to discuss plays for three stocks including: Humana, D.R. Horton and Tesla.

Persons: Horton, Tesla Organizations: Tesla, Nations

☆ S&P 500 futures are little changed Monday evening: Live updates
▼ + stars: | 2024-04-01 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Traders work on the floor of the New York Stock Exchange on April 1, 2024. Futures tied to the S&P 500 were little changed Monday night after the broad market index and the Dow Jones Industrial Average slipped to begin April. S&P 500 futures and Nasdaq 100 futures each dipped lower by less than 0.1%. Futures tied to the 30-stock Dow slipped 118 points, or 0.3%, as shares of UnitedHealth fell. To conclude Monday's session, the Dow fell nearly 241 points, or 0.6%, while the S&P 500 slid 0.2%.

Persons: Dow, UnitedHealth, David Miller, — Organizations: New York Stock Exchange, Dow Jones, Nasdaq, Medicare, Services, Humana, CVS Health, Federal Reserve, Catalyst Capital Advisors, CNBC, Labor, Survey Locations: UnitedHealth

☆ These stocks may have trouble living up to expectations for a big earnings turnaround this year
▼ + stars: | 2024-03-26 | by ( Pia Singh | ) www.cnbc.com time to read: +3 min

This in effect creates an 'implied' 2H of 2024 guidance that is perhaps excessively optimistic," CEO Adam Parker wrote Sunday. Parker's warning comes after S & P 500 reported earnings growth of 4.2% for the fourth quarter on a year-over-year basis, per FactSet. He also screened for stocks in which there's a big difference between earnings expectations for the first and the second half of the year. Parker surmises that these stocks may disappoint on these aggressive earnings turnarounds. Consensus estimates from analysts surveyed by FactSet suggest the stock, which is down nearly 5% this year, could gain 13.2% from Monday's close.

Persons: Adam Parker, Parker, AbbVie, FactSet, Wells Fargo, Estee Lauder Organizations: Research, Abbott Laboratories, Humana, Pharmaceutical, FactSet, Mondelez International, Procter, Gamble Locations: —, China, Monday's

☆ Stocks with high dividend growth and free cash flow perform best whatever the weather, Wolfe says
▼ + stars: | 2024-03-06 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

Stocks that offer high dividend growth and high free cash flow perform best no matter the economic weather, according to Wolfe Research. Here are a few stocks that fit the bill, according to Senyek: Online marketplace eBay was one of several stocks that Wolfe singled out. With its 4% yield, CVS is also a good buy for investors focusing on a high-dividend growth, high free cash flow strategy, Wolfe said. Following CVS' earnings release, investment bank Leerink initiated research coverage of the stock with an outperform rating , citing its cash potential. Other stocks Wolfe included on its list were Constellation Energy , Humana and Archer-Daniels-Midland .

Persons: Chris Senyek, Wolfe, UnitedHealth, Andrew Mok, Tom Cowhey, — CNBC's Michael Bloom Organizations: Wolfe Research, eBay, Barclays, Medicare, CVS, Constellation Energy, Humana, Archer, Daniels, Midland

☆ These are the most overbought stocks with the market at a record, including General Electric
▼ + stars: | 2024-03-01 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

The S & P 500 hit a fresh intraday record on Friday, building on what was a stellar February for Wall Street. But some stocks on Wall Street may be getting ahead of themselves, while others that have been under pressure could reverse course. Using our stock screener tool, CNBC Pro searched for the most overbought and oversold stocks on Wall Street, measured by their 14-day relative strength index (RSI). Stocks with a 14-day RSI above 70 are thought to be overbought, indicating that shares could soon experience a downturn. Shares of renewable energy firm Constellation Energy are also among the most overbought stocks on Wall Street, with a 14-day RSI of 85.6.

Persons: Insulet Organizations: Wall, Nasdaq, CNBC Pro, Electric, GE, General, GE Aerospace, Constellation Energy, Constellation, FactSet, Health, Humana, LSEG Locations: Wells Fargo

☆ ‘Fear is not a strategy’ — How Jim Cramer learned to make the most of market sell-offs
▼ + stars: | 2024-02-29 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +10 min

"You want to be able to embrace the sell-off and say, 'OK, it's going to get me my price,'" Jim said. During these declines, Jim said to focus on a stock's price and pick a level to start buying. Let the other people give you your price," Jim said. "If you just wake up one morning and say, 'Listen, I can't take it anymore,' that's going to be a bad buy," Jim said. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Persons: Jim Cramer, Jeff Marks, Here's, — Emanuel, Jim, Peter, Jeff, Wells, — Ben, they'd, destocking, Seth, we've, it's, hasn't, Eaton, — David, — Kyle, you've, It's, Jim Cramer's Organizations: Humana, DuPont, Eaton Corp, Palo Alto Networks, Enphase Energy, CNBC Locations: Wells Fargo, Eaton

☆ 2 startups posted big membership growth in the lucrative senior health plan business — after other young insurers failed
▼ + stars: | 2024-02-21 | by ( ) www.businessinsider.com time to read: +6 min

Just a few years ago, a crop of venture-backed health insurance startups embarked on planting a flag in the crowded but lucrative health plan business for seniors. Bright Health, which has exited the insurance business entirely as of this year, sold its Medicare Advantage plans in December. However, there are signs that the Medicare Advantage business isn’t as much of a goldmine as it used to be. It takes an enormous amount of capital to grow big in the insurance business, Fidel said. Its Medicare Advantage membership totals about 4 million.

Persons: haven’t, Stephens, underscoring, Oscar Health, Clover, Cowen, Gary Taylor, didn’t, Scott Fidel, it’s, they’ll, Fidel, UnitedHealthcare Organizations: Alignment Healthcare, Medicare, Business, Bright, Oscar, Services, Humana, CVS Health, Aetna, CVS Locations: California, New Jersey

CVS, which owns health insurer Aetna, on Wednesday slashed its full-year profit outlook, citing the potential for higher medical costs to bite into its profits. Last month, Humana said it saw an even bigger jump in medical costs in the fourth quarter. Higher medical costs may be a larger problem for Humana than they are for CVS and other insurers. They added that there is no other part of Humana's business that could meaningfully dampen the hit from higher medical costs on the insurance side. Another insurance giant that has been seeing higher medical costs, UnitedHealth Group, also has large health-care services and pharmacy operations that diversify its earnings streams.

Persons: Humana Organizations: CVS, Aetna, Medicare, Elevance, Humana, UBS, UnitedHealth

☆ CVS beats estimates, but cuts full-year profit outlook on higher medical costs
▼ + stars: | 2024-02-07 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

CVS Health on Wednesday reported fourth-quarter revenue and adjusted earnings that topped expectations, but the company cut its full-year profit outlook, citing higher medical costs that are dogging the broader insurance industry. The company lowered its 2024 adjusted earnings forecast to at least $8.30 per share, down from a previous guidance of at least $8.50 per share. Analysts surveyed by LSEG were expecting full-year adjusted earnings of $8.49 per share. CVS also cut its unadjusted earnings guidance to $7.06 per share, down from at least $7.26 per share. Excluding certain items, such as amortization of intangible assets and capital losses, adjusted earnings per share were $2.12 for the quarter.

Persons: LSEG Organizations: CVS Health, CVS, Aetna, LSEG, Oak Street Health

☆ Here are Jim Cramer’s rapid-fire takes on 5 stocks in the news Wednesday
▼ + stars: | 2024-02-07 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +2 min

"I think you should still buy Baba in light of the fact the Chinese government is panicking about their stocks," Jim Cramer said, referencing recent stimulus efforts in the country . CVS Health : Despite lowering its 2024 adjusted earnings outlook due to higher medical costs, shares of CVS Health climbed more than 3% Wednesday. "Aetna is better than people think, and I think that [CEO] Karen Lynch is better than people think," Jim said. New York Community Bancorp : Moody's Investor Service downgraded the regional bank's credit rating to junk, roughly a week after NYCB reported a surprise fourth-quarter loss and cut its dividend payout. However, "you can't boost confidence once you cut your dividend," Jim said, adding that "you can't buy" shares of NYCB right now.

Persons: Jim Cramer, Aetna, Karen Lynch, Jim, NYCB, Morgan Stanley, Uber, Roblox Organizations: CVS, CVS Health, Aetna, York Community Bancorp, Moody's Investor Service, CNBC, Club, Technologies Locations: Wells Fargo

☆ The red-hot health-plan business for seniors is finally cooling off
▼ + stars: | 2024-02-06 | by ( ) www.businessinsider.com time to read: +6 min

Read previewHealth insurance giant Cigna is exiting the lucrative senior business that's been a boon to insurers' bottom lines for years. It's a sign that the glory days of Medicare Advantage might be coming to an end. Cigna's senior business isn't the biggest, but it's also nothing to sneeze at. In January, Humana, the second-largest Medicare Advantage insurer with 6 million members, slashed its profit projections because of these costs. AdvertisementIn late 2023, rumors swirled that Cigna was looking to sell its Medicare Advantage plans so it could pull off a merger with Humana—the second-largest Medicare Advantage insurer.

Persons: —, that's, Cigna, it's, It's, David Cordani, Cordani, Gary Taylor, Cowen, Taylor, Dean Ungar, Humana, Ungar Organizations: Service, Health Care Service Corp, Medicare, Business, Kaiser Family Foundation, Competition, Humana, Moody's Investors Service Locations: Illinois

☆ Here are Jim Cramer's rapid-fire takes on 5 stocks in the news Monday
▼ + stars: | 2024-02-05 | by ( Paulina Likos | ) www.cnbc.com time to read: +1 min

Jim Cramer said this deal is Novo's way to "get more product" and addresses the "tremendous shortage" of these high-demand drugs. Shares of Eli Lilly , a stock in the CNBC Investing Club 's portfolio, were also up more than 4% ahead of Tuesday's earnings. Snap – The social media firm laid off 10% of its workforce ahead of Tuesday's earnings. Jim pointed out that Club name Starbucks (SBUX) has also been experiencing the same thing. Jim said buy McDonald's stock on weakness.

Persons: Jim Cramer, Eli Lilly, Lilly, Cramer, Cigna –, Cantor Fitzgerald, Jim Organizations: Nordisk, Catalent, CNBC, Microsoft, RBC Capital, Humana, Starbucks, Mattel –, JPMorgan, Vision, Apple Locations: Danish, Israel

☆ Here are Thursday's biggest analyst calls: Nvidia, Apple, Microsoft, Qualcomm, Target, AT&T, Tesla & more
▼ + stars: | 2024-02-01 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Here are Thursday's biggest calls on Wall Street: Morgan Stanley downgrades ZoomInfo to equal weight from overweight Morgan Stanley said it sees a slowing recovery for the software company. Morgan Stanley reiterates General Motors as overweight Morgan Stanley said it's standing by the auto giant and that GM shares are "cheap." Mizuho reiterates Nvidia as buy Mizuho said it's standing by the stock heading into its GTC Conference in March. Morgan Stanley names Docebo a top pick Morgan Stanley named the ed-tech company a top pick. " Morgan Stanley reiterates Bloom Energy as overweight Morgan Stanley said the energy company is an "underappreciated AI winner."

Persons: Morgan Stanley downgrades ZoomInfo, Morgan Stanley, Oppenheimer, AAPL, it's, Mizuho, Goldman Sachs, Goldman, Redburn, Tesla, Daiwa, Jefferies, StoneCo, Wells, JPMorgan downgrades Lennox, LII, Docebo, Kraft Heinz, Mondelez, Kate McShane, Wolfe, Cash Organizations: OW, Apple, Motors, Nvidia, Conference, Citi, Qualcomm, Samsung, Deutsche Bank, Deutsche, Humana, Microsoft, Rockwell Automation, Rockwell, JPMorgan, UBS, SilverBow Resources, Regency, Kraft, Target, RBC downgrades New York Community Bancorp, RBC, New, Community Bancorp, Bloom Energy, Boston Scientific, Mizuho Locations: Boston

☆ Exclusive: AI healthcare software startup Cohere Health just raised $50 million
▼ + stars: | 2024-02-01 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +4 min

Cohere Health just landed $50 million in Series B extension funding, Business Insider has learned exclusively. Deerfield Management led the Series B extension, with participation from Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners. The Cohere Health team. This year, as it works to get more health plans to use its software, Cohere plans to grow its workforce. In the second quarter of this year, Cohere plans to announce software that will apply AI to medical imaging.

Persons: Siva Namasivayam, Cohere, Axios, Namasivayam, It's, Michael Greeley, Lynne Chou O'Keefe, Greeley, Cohere's Organizations: Cohere, Business, Deerfield Management, Define Ventures, Flare Capital, Longitude, Polaris Partners, Humana, Capital Partners, Cohere Health Locations: Deerfield, Cohere

The firm named the stock a top pick for 2024 and reiterated an overweight rating alongside a $105 per share price target. The firm downgraded the health insurance stock to neutral from buy, and lowered its price target to $370 per share from $530. Sur reiterated an underweight rating on Intel stock alongside a $37 per share price target, or more than 25% downside moving forward. Deutsche Bank's Ross Seymour reiterated a hold rating on the stock as well as a $42 per share price target, implying about 15% downside. Analysts Benjamin Black upgraded the Snapchat parent company to buy from hold and raised his price target to $19 from $10.

Persons: Oppenheimer, Wells, Timur Braziler, — Brian Evans, AJ Rice, Brian Evans, Piper Sandler downgrades, Bancorp Piper Sandler, Piper Sandler's, Scott Siefers, Harlan Sur, Sur, America's Vivek Arya, Arya, Deutsche Bank's Ross Seymour, Seymour, Owen Lau, Lau, Coinbase, Analysts Benjamin Black, Black, Fred Imbert Organizations: CNBC, Deutsche Bank, UBS downgrades Humana, UBS, Humana, Piper Sandler downgrades U.S, Bancorp, U.S . Bancorp, Intel, . Bank, America's, GM, Deutsche, U.S . Securities, Exchange Commission, Analysts Locations: Wells Fargo, Puerto Rican, ., Coinbase, Thursday's, China

Search resuls for: "Humana"

25 mentions found